Compare FCFS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FCFS | CRL |
|---|---|---|
| Founded | 1988 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 8.0B |
| IPO Year | 1991 | 2000 |
| Metric | FCFS | CRL |
|---|---|---|
| Price | $158.50 | $193.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $168.75 | ★ $190.15 |
| AVG Volume (30 Days) | 237.4K | ★ 931.1K |
| Earning Date | 01-29-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | ★ 27.90 | N/A |
| EPS | ★ 6.92 | N/A |
| Revenue | $3,486,435,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $8.28 | N/A |
| Revenue Next Year | $10.44 | $1.66 |
| P/E Ratio | $22.56 | ★ N/A |
| Revenue Growth | ★ 3.86 | N/A |
| 52 Week Low | $100.24 | $91.86 |
| 52 Week High | $166.08 | $202.72 |
| Indicator | FCFS | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 69.52 |
| Support Level | $154.57 | $176.37 |
| Resistance Level | $163.25 | $186.72 |
| Average True Range (ATR) | 4.68 | 6.00 |
| MACD | -0.10 | 2.11 |
| Stochastic Oscillator | 70.51 | 98.84 |
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.